AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Noseworthy, JH Poland, GA
Citation: Jh. Noseworthy et Ga. Poland, Multiple sclerosis - Reply, N ENG J MED, 344(5), 2001, pp. 382-382

Authors: Noseworthy, JH O'Brien, PC Petterson, TM Weis, J Stevens, L Peterson, WK Sneve, D Cross, SA Leavitt, JA Auger, RG Weinshenker, BG Dodick, DW Wingerchuk, DM Rodriguez, M
Citation: Jh. Noseworthy et al., A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis, NEUROLOGY, 56(11), 2001, pp. 1514-1522

Authors: Wingerchuk, DM Lucchinetti, CF Noseworthy, JH
Citation: Dm. Wingerchuk et al., Multiple sclerosis: current pathophysiological concepts, LAB INV, 81(3), 2001, pp. 263-281

Authors: Whitaker, JN Wolinsky, JS Narayana, PA Bartolucci, AA Noseworthy, JH Lublin, FD Linde, A Gjorstrup, P Sullivan, HC
Citation: Jn. Whitaker et al., Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis, ARCH NEUROL, 58(1), 2001, pp. 49-54

Authors: Weinshenker, BG Noseworthy, JH
Citation: Bg. Weinshenker et Jh. Noseworthy, Multiple sclerosis: Study design, sample sizes and pitfalls, CLINICAL TRIALS IN NEUROLOGY, 2001, pp. 371-385

Authors: Noseworthy, JH Lucchinetti, C Rodriguez, M Weinshenker, BG
Citation: Jh. Noseworthy et al., Medical progress: Multiple sclerosis., N ENG J MED, 343(13), 2000, pp. 938-952

Authors: Noseworthy, JH O'Brien, PC Weinshenker, BG Weis, JA Petterson, TM Erickson, BJ Windebank, AJ Whisnant, JP Stolp-Smith, KA Harper, CM Low, PA Romme, LJ Johnson, M An, KN Rodriguez, M
Citation: Jh. Noseworthy et al., IV immunoglobulin does not reverse established weakness in MS - A double-blind, placebo-controlled trial, NEUROLOGY, 55(8), 2000, pp. 1135-1143

Authors: Noseworthy, JH Wolinsky, JS Lublin, FD Whitaker, JN Linde, A Gjorstrup, P Sullivan, HC
Citation: Jh. Noseworthy et al., Linomide in relapsing and secondary progressive MS - Part I: Trial design and clinical results, NEUROLOGY, 54(9), 2000, pp. 1726-1733

Authors: Wolinsky, JS Narayana, PA Noseworthy, JH Lublin, FD Whitaker, JN Linde, A Gjorstrup, P Sullivan, HC
Citation: Js. Wolinsky et al., Linomide in relapsing and secondary progressive MS - Part II: MRI results, NEUROLOGY, 54(9), 2000, pp. 1734-1741

Authors: Jagust, WJ Noseworthy, JH
Citation: Wj. Jagust et Jh. Noseworthy, Brain atrophy as a surrogate marker in MS - Faster, simpler, better?, NEUROLOGY, 54(4), 2000, pp. 782-783

Authors: Noseworthy, JH Gold, R Hartung, HP
Citation: Jh. Noseworthy et al., Treatment of multiple sclerosis: recent trials and future perspectives, CURR OP NEU, 12(3), 1999, pp. 279-293

Authors: Weinshenker, BG O'Brien, PC Petterson, TM Noseworthy, JH Lucchinetti, CF Dodick, DW Pineda, AA Stevens, LN Rodriguez, M
Citation: Bg. Weinshenker et al., A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease, ANN NEUROL, 46(6), 1999, pp. 878-886

Authors: Schwid, SR Noseworthy, JH
Citation: Sr. Schwid et Jh. Noseworthy, Targeting immunotherapy in multiple sclerosis - A near hit and a clear miss, NEUROLOGY, 53(3), 1999, pp. 444-445

Authors: Wingerchuk, DM Noseworthy, JH Kimmel, DW
Citation: Dm. Wingerchuk et al., Paraneoplastic disorders associated with seminoma - Reply, NEUROLOGY, 53(3), 1999, pp. 659-659

Authors: Noseworthy, JH
Citation: Jh. Noseworthy, Progress in determining the causes and treatment of multiple sclerosis, NATURE, 399(6738), 1999, pp. A40-A47

Authors: Noseworthy, JH
Citation: Jh. Noseworthy, Advances in multiple sclerosis research - Preface, SEM NEUROL, 18(3), 1998, pp. 283-283

Authors: Noseworthy, JH
Citation: Jh. Noseworthy, Multiple sclerosis clinical trials: Old and new challenges, SEM NEUROL, 18(3), 1998, pp. 377-388

Authors: Dodick, DW Silber, MH Noseworthy, JH Wilbright, WA Rodriguez, M
Citation: Dw. Dodick et al., Acute disseminated encephalomyelitis after accidental injection of a hog vaccine: Successful treatment with plasmapheresis, MAYO CLIN P, 73(12), 1998, pp. 1193-1195
Risultati: 1-18 |